These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34710494)

  • 1. Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
    Ahmed S; Ahmed A; Rådegran G
    Int J Cardiol; 2021 Dec; 345():68-76. PubMed ID: 34710494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data on plasma tumour and metabolism related proteins' potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension.
    Ahmed S; Ahmed A; Rådegran G
    Data Brief; 2022 Feb; 40():107747. PubMed ID: 35024391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.
    van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS
    Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension.
    Arvidsson M; Ahmed A; Bouzina H; Rådegran G
    ESC Heart Fail; 2021 Apr; 8(2):1230-1243. PubMed ID: 33403810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction.
    Thenappan T; Shah SJ; Gomberg-Maitland M; Collander B; Vallakati A; Shroff P; Rich S
    Circ Heart Fail; 2011 May; 4(3):257-65. PubMed ID: 21411741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension.
    Ahmed A; Ahmed S; Rådegran G
    Pulm Circ; 2021; 11(4):20458940211041500. PubMed ID: 34616545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction.
    Olsson KM; Sommer L; Fuge J; Welte T; Hoeper MM
    Respir Res; 2015 Mar; 16(1):34. PubMed ID: 25853979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study.
    Baratto C; Caravita S; Dewachter C; Faini A; Perego GB; Bondue A; Senni M; Muraru D; Badano LP; Parati G; Vachiéry JL
    J Card Fail; 2023 Sep; 29(9):1261-1272. PubMed ID: 37150503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension.
    Arvidsson M; Ahmed A; Säleby J; Ahmed S; Hesselstrand R; Rådegran G
    Pulm Circ; 2023 Jul; 13(3):e12269. PubMed ID: 37502145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
    Jheng JR; DesJardin JT; Chen YY; Huot JR; Bai Y; Cook T; Hibbard LM; Rupp JM; Fisher A; Zhang Y; Duarte JD; Desai AA; Machado RF; Simon MA; Lai YC
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1570-1583. PubMed ID: 38813697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.
    Levine AR; Simon MA; Gladwin MT
    Trends Cardiovasc Med; 2019 May; 29(4):207-217. PubMed ID: 30177249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.
    Salamon JN; Kelesidis I; Msaouel P; Mazurek JA; Mannem S; Adzic A; Zolty R
    J Card Fail; 2014 Jul; 20(7):467-75. PubMed ID: 24858070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF.
    Berthelot E; Montani D; Algalarrondo V; Dreyfuss C; Rifai R; Benmalek A; Jais X; Bouchachi A; Savale L; Simonneau G; Chemla D; Humbert M; Sitbon O; Assayag P
    J Card Fail; 2017 Jan; 23(1):29-35. PubMed ID: 27742455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension.
    Kania K; Ahmed A; Ahmed S; Rådegran G
    ESC Heart Fail; 2022 Dec; 9(6):4139-4149. PubMed ID: 36082780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
    Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
    Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Pulmonary Hypertension in Left Heart Disease.
    Macera F; Vachiéry JL
    Methodist Debakey Cardiovasc J; 2021; 17(2):115-123. PubMed ID: 34326931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.